About the Conference

The Trans-Pacific Health Sciences Dialogue is a meeting for C-level biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.

This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.

Take a look at some photos from the 2014 Trans-Pacific Health Sciences Dialogue!

Day 1 PhotosDay 2 Photos

In 2015, the Trans-Pacific Health Sciences Dialogue will be held at:

Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115

Boston_small

Sponsors

Sponsors_200px

Supporters

Supporters_200px

Who Should Attend

WhoShouldAttend

The Trans-Pacific Health Sciences Dialogue is an event for senior biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.

Industry News from FiercePharmaAsia

Read more

Industry News from PharmAsia

  • Second Asian Deal Helps Resurrect Ablynx’s OzoralizumabBelgium's Ablynx has chosen Taisho as its partner for the development in Japan of a nanobody therapy for rheumatoid arthritis, marking both the first step towards a commercial presence for Ablynx in the country and the second Asian licensing deal for the formerly shelved molecule.<img src="http://feeds.feedburner.com/~r/_PharmAsiaNews/~4/HvdzHEt82tw" height="1" width="1" alt="" />
Read more